Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Soleno Therapeutics (SLNO) Accounts Payables: 2013-2018

Historic Accounts Payables for Soleno Therapeutics (SLNO) over the last 6 years, with Dec 2018 value amounting to $934,000.

  • Soleno Therapeutics' Accounts Payables rose 39.36% to $1.7 million in Q3 2019 from the same period last year, while for Sep 2019 it was $1.7 million, marking a year-over-year increase of 39.36%. This contributed to the annual value of $934,000 for FY2018, which is 47.55% up from last year.
  • Per Soleno Therapeutics' latest filing, its Accounts Payables stood at $934,000 for FY2018, which was up 47.55% from $633,000 recorded in FY2017.
  • Soleno Therapeutics' Accounts Payables' 5-year high stood at $986,799 during FY2014, with a 5-year trough of $410,512 in FY2016.
  • Its 3-year average for Accounts Payables is $659,171, with a median of $633,000 in 2017.
  • As far as peak fluctuations go, Soleno Therapeutics' Accounts Payables skyrocketed by 1,609.60% in 2014, and later slumped by 40.94% in 2016.
  • Soleno Therapeutics' Accounts Payables (Yearly) stood at $986,799 in 2014, then dropped by 29.56% to $695,056 in 2015, then slumped by 40.94% to $410,512 in 2016, then spiked by 54.20% to $633,000 in 2017, then skyrocketed by 47.55% to $934,000 in 2018.